• January 7, 2015
    FLORHAM PARK, N.J., Jan. 7, 2015 — Fostera® PRRS, from Zoetis, is now licensed for whole herd protection against both the respiratory and reproductive forms of disease caused by porcine reproductive and respiratory syndrome (PRRS) virus.The new reproductive claim, recently granted by the U.S. Department of Agriculture (USDA), allows for vaccination of sows and gilts prebreeding to help provide protection against the reproductive form of the disease. The new respiratory claim allows formore...
  • December 31, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (EST) on Wednesday, Feb. 11, 2015. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Paul Herendeen will review fourth quarter and full year 2014 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetismore...
  • December 17, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2015 dividend payable to holders of the company’s common stock of $0.083 per share, an increase of 15% from the quarterly dividend rate paid in 2014. The dividend is to be paid on Tuesday, Mar. 3, 2015, to holders of record on Thursday, Jan. 22, 2015. “In 2014, we continued to demonstrate the strength of our business model and deliver our long-term valuemore...
  • December 17, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 14, in San Francisco, Calif. Juan Ramón Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 1:00 p.m. EST (10:00 a.m. PST). Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://more...
  • December 2, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Animal & Dental Health Summit on Thursday, Dec. 11, in Boston, Mass. Paul Herendeen, Executive Vice President and Chief Financial Officer, and Clint Lewis, Executive Vice President and President, U.S. Operations, will represent the company and respond to questions from analysts. They are scheduled to present at 12:30 p.m. EST. The meeting is not scheduledmore...
  • December 1, 2014
    FLORHAM PARK, N.J., December 1, 2014 – Zoetis is pleased to announce that the American Animal Hospital Association (AAHA) has selected the company’s Pet Wellness Report® (PWR) as AAHA’s exclusive Preferred Business Provider for Health Risk Assessments in veterinary medicine. AAHA accredited hospitals are traditionally on the forefront of advancing new approaches to medical care for companion animals. The endorsement lends credibility to this innovative communication tool, which furthermore...
  • November 24, 2014
    QINGDAO, CHINA - November 24, 2014 - Zoetis, the Chinese Veterinary Medical Association (CVMA), and Kansas State University (KSU) signed a Memorandum of Understanding to work together and promote the Doctor of Veterinary Program (DVM) in China. This program aims to enhance veterinary services and veterinary training in the country by sharing the collective resources and providing other necessary support.The agreement was signed at the International Symposium on Veterinary Education held inmore...
  • November 24, 2014
    DURHAM, N.C. - November 24, 2014 – Zoetis Inc. today announced the reintroduction of Zoamix® (zoalene), a versatile synthetic anticoccidial for the prevention and control of coccidiosis in broilers and turkeys.“The U.S. poultry industry loses an estimated $600 million a year to coccidiosis[i], so the return of Zoamix could not be coming at a better time,” said Don Waldrip, DVM, DACPV, a senior technical services veterinarian with Zoetis.He noted that U.S. poultry producers have not seen a newmore...
  • November 24, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Roman Trawicki as President of its Global Manufacturing and Supply organization. With more than 20 years of broad, international experience in healthcare manufacturing and operations, Mr. Trawicki will oversee the company’s global manufacturing and supply network that produces more than 300 animal health product lines for the company. As the world leader in animal health, Zoetismore...
  • November 18, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS), the world’s leading animal health company, today hosted its first-ever Investor Day, discussing with investors and analysts the company’s leadership position in the animal health industry and the strategy and initiatives underway that will drive growth and create value for shareholders. The company also provided full-year 2015 financial guidance and outlined its longer term financial goals through 2017. “more...